Viewing nowVIVACO Tablet 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

MFDS item code 201400433 · Approved 2014.01.29 · Insurance code 640006750
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when diet and exercise are insufficient to control primary hypercholesterolemia and mixed dyslipidemia. It is also suitable as a dietary therapy adjunct for patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia. Additionally, it lowers total cholesterol and LDL cholesterol in patients with hypercholesterolemia, delaying the progression of atherosclerosis, and has an effect of reducing LDL cholesterol and apo-B protein levels in certain pediatric patients. In high-risk patients with cardiovascular disease risk factors, it helps to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures. Therefore, it is used to improve cardiovascular health and prevent related diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 mg per day. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medication is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on administering doses higher than 20 mg to pediatric patients.) Maximum daily dose: 20 mg. The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Children under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients who are allergic to any component of this medication, have liver dysfunction, have muscle disorders, have severe renal impairment, or are pregnant or breastfeeding should not take this medication. In addition, this medication carries a risk of muscle-related side effects, so patients who are prone to myopathy or rhabdomyolysis should be particularly cautious. Risk factors include renal impairment, hypothyroidism, family history or genetic muscle disorders, and alcohol abuse. This medication contains lactose, so patients with lactose intolerance or related genetic conditions should not take it. It is important to regularly check liver function and muscle condition while taking this medication. Special caution should be taken if one drinks alcohol excessively or has a history of liver disease, and if symptoms such as muscle pain, weakness, or fatigue occur, one should consult a doctor immediately. This medication may interact with other drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Taking this medication with certain medications may increase its blood concentration and the risk of side effects. Women who could become pregnant should use appropriate contraception before taking this medication, and should avoid taking it during pregnancy or while breastfeeding. There is no specific antidote for overdose, so treatment should be based on symptoms, and liver function and muscle condition should be monitored. Caution is needed when driving or operating machinery as dizziness may occur.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distention, abnormal liver function tests, syncope, widespread pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication’s efficacy over a longer period.
Pink round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.